P79.02 Updated OS and Time to Second Progression with First-Line Camrelizumab Plus Chemo vs Chemo for Advanced Non-Squamous NSCLCC. Zhou, Chengping Hu, Yunchao Huang et al.|Journal of Thoracic Oncology|2021Cited by 7